Hepatitis B Vaccine (Recombinant) [clinicaltrials_resource:457b53b3e05afb56cf97a21faf6ea4ed]
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals [clinicaltrials:NCT00000633]A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160 [clinicaltrials:NCT00000745]A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328 [clinicaltrials:NCT00000943]Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV [clinicaltrials:NCT00001119]Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs [clinicaltrials:NCT00013871]
intervention [clinicaltrials_vocabulary:intervention]
Hepatitis B Vaccine (Recombinant) [clinicaltrials_resource:457b53b3e05afb56cf97a21faf6ea4ed]
Bio2RDF identifier
457b53b3e05afb56cf97a21faf6ea4ed
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:457b53b3e05afb56cf97a21faf6ea4ed
intervention name [clinicaltrials_vocabulary:intervention-name]
Hepatitis B Vaccine (Recombinant)
identifier
clinicaltrials_resource:457b53b3e05afb56cf97a21faf6ea4ed
title
Hepatitis B Vaccine (Recombinant)
@en
type
label
Hepatitis B Vaccine (Recombina ...... b53b3e05afb56cf97a21faf6ea4ed]
@en